The 20 Best Prostate Cancer Doctors Near Me in Ann Arbor, MI
Find the Top Prostate Cancer Experts and Specialists
Michigan Institute Of Urology
Jason Hafron is a Urologist practicing medicine in Troy, Michigan. He has been practicing medicine for over 26 years. Dr. Hafron is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Enlarged Prostate (BPH), Familial Prostate Cancer, Prostatectomy, and Aquablation. Dr. Hafron is board certified in American Board Of Urology. Dr. Hafron is currently accepting new patients.
Wayne Health
Michael Cher is a Urologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 40 years. Dr. Cher is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Prostatectomy, and Ureteral Reconstruction. Dr. Cher is board certified in American Board Of Urology. Dr. Cher is currently accepting new patients.
Rose Cancer Treatment Center
Daniel Krauss is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. Dr. Krauss is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Gamma Knife Radiosurgery, and Prostatectomy. Dr. Krauss is board certified in American Board Of Radiology. Dr. Krauss is currently accepting new patients.
Are you looking for a specific type of Prostate Cancer?
Common conditions include: Familial Prostate Cancer
Brighton Center For Specialty Care
I came to the University of Michigan as a Robert Wood Johnson Clinical Scholar in 1997, following the completion of my urologic training at Cornell University-New York Hospital. During the fellowship, I also obtained a Masters degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health. Even more importantly, I was inspired by my mentors including Rodney Hayward and James Montie to train others to conduct high quality research. I then stayed on to join the University of Michigan faculty as an Assistant Professor in 1999. In 2004, I was promoted to Associate Professor, and in 2009, I was promoted to Professor of Urology. Dr. Wei is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Enlarged Prostate (BPH), Urinary Incontinence, Prostatectomy, and Cystectomy. Dr. Wei is board certified in Urology.
University Hospital
Dr. Dess is an Associate Professor in the Department of Radiation Oncology at the University of Michigan.He attended medical school at University of Chicago and completed his residency in radiation oncology at the University of Michigan.He practices in several locations. At the University of Michigan Ann Arbor main campus, he is the co-Chief of Genitourinary Radiotherapy Service, and also leads the high dose rate (HDR) prostate brachytherapy program. At the Brighton Center for Specialty Care, he serves as the primary genitourinary radiation oncologist.Dr. Dess is a clinical and translational researcher focused on genitourinary malignancy. He has worked with a global network of collaborators to create novel prognostic models to characterize prostate cancer disease aggressiveness, to identify novel prognostic and predictive biomarkers, to analyze racial outcomes differences and settings in which disparities are minimized, and to advance more convenient forms of treatment including stereotactic body radiation therapy (SBRT) and high-dose rate brachytherapy (HDR). He is interested in maximizing efficacy, minimizing burden, and understanding the long-term toxicity risks of treatment. His work has been published high profile in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, and JAMA Oncology.Dr. Dess also serves as the co-lead for prostate cancer within the Michigan Radiation Oncology Quality Consortium (MROQC) where he works to improve state-wide care. Dr. Dess is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Dess is board certified in Radiation Oncology.
Henry Ford Hospital
Akshay Sood is a Urologist practicing medicine in Detroit, Michigan. Dr. Sood is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Urothelial Cancer, Prostatectomy, and Nephrectomy.
Taubman Center
Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation. Dr. Salami is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Salami is board certified in Urology.
Rogel Cancer Center
Zachery Reichert is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Reichert is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.
Rogel Cancer Center
Dr. David Smith is a Professor of Internal Medicine and Urology at the University of Michigan and currently serves as the Associate Chief Clinical Officer for Cancer at Michigan Medicine and the Chief Medical Officer of the Rogel Cancer Center. Throughout his career he has focused on caring for patients with urologic cancers, cancer clinical trials, and the delivery of cancer care. Dr. Smith is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy.
Rogel Cancer Center
Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.
University Of Michigan Medical Center
Ajjai Alva is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Alva is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Lymphadenectomy.
Karmanos Cancer Center
Elisabeth Heath is an Oncologist practicing medicine in Detroit, Michigan. Dr. Heath is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy.
Rogel Cancer Center
Brent K. Hollenbeck, M.D., M.S. is a practicing urologic oncologist and has been on faculty at the University of Michigan since 2003. A graduate of the Indiana University School of Medicine, Dr. Hollenbeck completed his residency in urology and fellowship training in oncology at the University of Michigan. During the past 5 years, his clinical practice has grown in patient volume, which complements his research imperative. Over this time, he has become increasingly specialized in the care of patients with prostate and bladder cancers. This focus has afforded him the ability to maintain his commitment to research while continuing to deliver cutting-edge, high quality care.Dr. Hollenbeck is currently an Associate Professor of Urology and the Director of the Herbert H. and Grace A. Dow Division of Health Services Research at the University of Michigan. He is firmly committed to training the future leaders in urologic health services research. Further, he strongly believes that populating the surgical specialties with health services researchers will yield long-term benefits to both our specialty and our patients.When he is not engaged in clinical and research pursuits, Brent is a very active swimmer, runner and fly fisherman (especially for steelhead). Perhaps most importantly, however, he enjoys spending the bulk of his free time with his wife and two daughters. The Hollenbecks are avid fans of Michigan athletics and look forward to cheering on the Wolverines on football Saturdays. Dr. Hollenbeck is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy.
Henry Ford Hospital
Mani Menon is a Urologist practicing medicine in Detroit, Michigan. Dr. Menon is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Cystectomy.
Henry Ford Medical Center-Lakeside
Firas Abdollah is a Urologist practicing medicine in Sterling Heights, Michigan. Dr. Abdollah is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Prostate Cancer, Urothelial Cancer, Prostatectomy, and Nephrectomy.
Michigan Institute Of Urology
Kenneth Kernen is a Urologist practicing medicine in Troy, Michigan. He has been practicing medicine for over 33 years. Dr. Kernen is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Enlarged Prostate (BPH), Perirenal Abscess, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kernen is board certified in American Board Of Urology. Dr. Kernen is currently accepting new patients.
Corewell Health Medical Oncology Program - Lemmen-Holton
Emerson Lim is a Hematologist Oncology specialist and an Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 20 years. Dr. Lim is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Clear Cell Sarcoma. Dr. Lim is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.
Michigan Institute Of Urology
James Relle is a Urologist practicing medicine in Troy, Michigan. He has been practicing medicine for over 38 years. Dr. Relle is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Enlarged Prostate (BPH), Kidney Stones, Ureteroscopy, and Prostatectomy. Dr. Relle is board certified in American Board Of Urology. Dr. Relle is currently accepting new patients.
Corewell Health Beaumont Troy Hospital Radiation Oncology
Zachary Seymour is a Radiation Oncologist practicing medicine in Troy, Michigan. Dr. Seymour is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Metastatic Brain Tumor, Primitive Neuroectodermal Tumor (PNET), Gamma Knife Radiosurgery, and Hormone Replacement Therapy (HRT). Dr. Seymour is board certified in American Board Of Radiology. Dr. Seymour is currently accepting new patients.
MHP Radiation Oncology Institute
Frank Vicini is a Radiation Oncologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 41 years. Dr. Vicini is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Prostatectomy. Dr. Vicini is board certified in American Board Of Radiology. Dr. Vicini is currently accepting new patients.
Last Updated: 04/28/2026















